Invizyne Technologies, Inc. is a developer and manufacturer of process modules and custom mixing systems designed for the chemical, pharmaceutical, life sciences, food and beverage, and consumer products industries. The company’s core offering centers on its patented OBS series mixing platform, which integrates advanced fluid dynamics and control technologies to deliver precise, scalable solutions for complex mixing, dispersion, and emulsification applications. Invizyne’s products support both research and development laboratories as well as full-scale production environments, helping clients accelerate product development and optimize manufacturing throughput.
In addition to its flagship mixing platforms, Invizyne provides a suite of complementary services that include system design and engineering, performance validation, and ongoing technical support. The company operates a fully equipped R&D facility in Massachusetts, where engineers collaborate closely with customers to customize modules, develop technical protocols, and ensure seamless integration with existing production lines. This emphasis on turnkey solutions enables companies in highly regulated sectors—such as pharmaceuticals and personal care—to meet stringent quality standards and reduce time to market for new formulations.
Founded in 2018 and headquartered in Franklin, Massachusetts, Invizyne Technologies has steadily expanded its footprint across North America, Europe, and the Asia-Pacific region. The company’s growth has been driven by rising demand for precision mixing technologies in high-value applications, including biologics manufacturing and advanced materials processing. Invizyne’s executive leadership team is led by Chief Executive Officer Shawn M. Gaffney, with Chief Financial Officer Remi Dufour overseeing corporate strategy and financial operations. Together, they continue to steer the company’s innovation roadmap and global expansion initiatives.
AI Generated. May Contain Errors.
Free IZTC Stock Alerts